Posted by Mary Helen Stoltz on February 2, 2016
Cancer screening could soon be as simple as giving a urine sample using a patented device developed by a Missouri University of Science and Technology researcher. This week, Wyoming-based Cancer.im Inc., a Viratech Corp. company (Symbol: VIRA) and social network for cancer patients, survivors and caretakers, announced an agreement with Missouri S&T to commercialize the device.Read More »
Posted by Mary Helen Stoltz on May 28, 2013
A Missouri University of Science and Technology researcher has developed a new screening method that uses urinalysis to diagnose breast cancer – and determine its severity – before it could be detected with a mammogram. A study to confirm this technique’s effectiveness is under way at Mercy Breast Center in Springfield, Mo.Read More »
Missouri S&T is an equal opportunity/access/affirmative action/pro-disabled and veteran employer and does not discriminate on the basis of sex in our education programs or activities, pursuant to Title IX and 34 CFR Part 106. For more information, see S&T's Nondiscrimination Policy or Equity and Title IX.